Postbiotic market seen reaching $3 billion by 2031

The global postbiotic market was valued at $1.6 billion in 2021 and is projected to hit $3 billion by 2031, driven by rising nutraceutical use, demand for gut and immune health supplements, and growing interest in functional foods and cosmetics. Regulatory hurdles in Europe and competition from other ingredient formats remain key constraints.

Why it matters: - Postbiotics are moving from a niche ingredient to a broader consumer health category as demand rises for supplements that support gut and immune health. - The market’s growth could reshape nutraceuticals, functional foods, cosmetics, and animal feed as manufacturers look for new product formats and claims. - Europe’s strict rules on health claims could slow commercialization and make scientific validation a bigger hurdle for brands.

What happened: - The postbiotic market was valued at $1.6 billion in 2021 and is projected to reach $3 billion by 2031. - The market is expected to grow at a compound annual growth rate of 6.8% from 2022 to 2031. - Allied Market Research released the report covering market size, share, competitive landscape and trend analysis by form, application and region. - The report includes postbiotic market segments for powder, liquid and other forms. - The report also breaks the market into personal care and cosmetics, food and beverage, animal feed, pharmaceuticals and other applications. - Regional coverage includes North America, Europe, Asia-Pacific and LAMEA. - Download the sample report - Make a purchase inquiry

The details: - Postbiotic consumption has risen alongside increased use of nutraceuticals and health supplements. - Some consumers are turning to postbiotic supplements because probiotic and prebiotic breakdown in the body may be insufficient. - Gummies, jellies and soft gels are gaining popularity because consumers want supplements that are convenient and tasty. - These newer nutraceutical formats come in multiple shapes, sizes, flavors and concentrations. - Many of the products are designed for daily use, which supports repeat consumption when consumers view them as enjoyable. - Children are an expanding consumer group for these nutraceutical formats. - Investment in R&D to find new postbiotic applications is increasing demand. - Postbiotic ingredients are widely used in cosmetics because they can support skin health and help prevent side effects from other ingredients. - Growth in fitness and sports participation is supporting interest in functional beverages. - Urbanization, higher healthcare spending and rising rates of cardiovascular, chronic and obesity-related diseases are also supporting category growth. - Europe was the largest market in the base year because consumers there adapt quickly to newer products and focus heavily on health and wellbeing. - North America was the second-largest market. - LAMEA is expected to grow at a CAGR of 6.0% by the end of the forecast period. - Asia-Pacific is expected to grow at a CAGR of 7.3% by the end of the forecast period. - Key companies in the market include Sami-Sabinsa Group Limited, Woresan GmbH, Novachem SRL, ILDONG HOLDINGS CO., LTD., Church & Dwight Co., Inc., Danish Agro, Lamberti S.p.A., Cargill, Incorporated, Adare Pharma Solutions, Lactobio A/S, Archer Daniels Midland Company, Kirin Holdings Company, Limited, Bioflag Group, Probiotics Australia Pty., Ltd., Lesaffre, Otemchi Biotechnologies Pte. Ltd., SILAB, Mitsubishi Corporation, GeneFerm Biotechnology Co., Ltd. and KOREA BeRM co., Ltd.

Between the lines: - The strongest near-term demand appears tied to formats that feel familiar and easy to take, which may favor gummies and soft gels over more traditional supplement forms. - Europe’s regulatory environment suggests product claims may matter as much as product performance, especially for companies trying to expand across borders. - The report’s regional growth outlook points to Asia-Pacific as the fastest-growing market among the named regions.

What’s next: - Postbiotic brands are likely to keep expanding into foods, beverages, cosmetics and health supplements as consumer interest broadens. - Companies pursuing growth will need stronger clinical evidence to support health claims, especially in regulated markets. - Product developers are expected to keep testing new delivery formats and applications to stand out in a crowded nutraceutical market.